<DOC>
	<DOCNO>NCT00670553</DOCNO>
	<brief_summary>The purpose study assess feasibility combine administration different LBH589 dosage radiotherapy order establish dosage evaluated future study .</brief_summary>
	<brief_title>A Phase I Study LBH589 ( Panobinostat ) Combination With External Beam Radiotherapy Treatment Prostate Cancer , Esophageal Cancer Head Neck Cancer</brief_title>
	<detailed_description />
	<mesh_term>Prostatic Neoplasms</mesh_term>
	<mesh_term>Head Neck Neoplasms</mesh_term>
	<mesh_term>Esophageal Neoplasms</mesh_term>
	<mesh_term>Panobinostat</mesh_term>
	<criteria>Inclusion criterion : Patients age â‰¥18 year Confirmed diagnosis prostate cancer , SCC esophageal cancer head &amp; neck cancer No evidence distant spread disease Exclusion criterion : Patients severe and/or uncontrolled medical condition Female patient pregnant breast feed Other protocoldefined inclusion/exclusion criterion may apply</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2016</verification_date>
	<keyword>Prostate ,</keyword>
	<keyword>Head &amp; Neck ,</keyword>
	<keyword>Esophageal</keyword>
</DOC>